How Amiloride Works
Amiloride works by directly blocking epithelial sodium channels (ENaC) in the distal collecting duct of the kidney, thereby inhibiting sodium reabsorption and reducing potassium excretion—functioning as an indirect aldosterone antagonist without requiring aldosterone receptor binding. 1
Mechanism of Action
Amiloride's primary mechanism involves reversible blockade of luminal epithelial sodium channels (ENaC) in the late distal tubule and collecting duct 2. This differs fundamentally from mineralocorticoid receptor antagonists like spironolactone:
- Direct ENaC inhibition: Amiloride binds to sites within the channel pore and extracellular domain, physically blocking sodium entry 3
- Aldosterone-independent action: Unlike spironolactone, amiloride's effects occur even in the absence of aldosterone 1
- Selective sodium transport blockade: By inhibiting sodium reabsorption, it reduces the net negative potential of the tubular lumen, which decreases both potassium and hydrogen secretion 1
Pharmacokinetics
The drug demonstrates predictable absorption and elimination:
- Onset: Begins acting within 2 hours of oral administration 1
- Peak effect: Electrolyte excretion changes peak between 6-10 hours 1
- Duration: Effects last approximately 24 hours, allowing once-daily dosing 4
- Peak plasma levels: Achieved in 3-4 hours 1
- Half-life: 6-9 hours 1
- Metabolism: Not metabolized by the liver; excreted unchanged by kidneys (50% urine, 40% stool within 72 hours) 1
Clinical Effects
Potassium-sparing diuresis: Amiloride produces mild natriuresis and diuresis while conserving potassium 1. When combined with thiazide or loop diuretics, it also decreases the enhanced urinary magnesium excretion that occurs with those agents alone 1.
Blood pressure reduction: The drug demonstrates antihypertensive effects through multiple mechanisms 5:
- In resistant hypertension studies, amiloride 10 mg daily reduced systolic/diastolic BP by 12.2/4.8 mm Hg compared to placebo 5
- When substituted as amiloride/hydrochlorothiazide combination, it lowered BP by 31/15 mm Hg in low-renin hypertension 5
Comparison to Spironolactone
Key mechanistic differences 5:
- Amiloride increases plasma renin activity (indicating ENaC blockade), while spironolactone does not
- Amiloride lacks the sex steroid-related side effects of spironolactone (no gynecomastia, menstrual irregularities) 6
- Recent evidence suggests amiloride may be as effective as spironolactone in resistant hypertension 7, 8
Beyond Renal Effects
Vascular biology: ENaC is also expressed in endothelial cells, where its activation reduces nitric oxide release, increases oxidative stress, and promotes vascular stiffness 8. Amiloride may improve endothelial function through ENaC inhibition, providing BP reduction beyond simple volume depletion 8.
Clinical Positioning
Current guideline recommendations 9:
- Useful for resistant edema in nephrotic syndrome when combined with loop diuretics
- Counters hypokalemia from thiazide or loop diuretics
- Helpful for metabolic alkalosis of diuresis
- Alternative to spironolactone when the latter is not tolerated 10, 7
Important caveat: Hyperkalemia risk increases in older patients, those with diabetes/CKD, or when combined with ACE inhibitors, ARBs, or NSAIDs 5. Close monitoring of serum potassium is essential.
The drug's aldosterone-independent mechanism makes it particularly valuable in patients who cannot tolerate mineralocorticoid receptor antagonists or in specific genetic conditions like Liddle syndrome where ENaC is constitutively activated 11, 12.